TR200809829T1 - HDAC inhibitörlerinin lenfoma tedavisine yönelik olarak kullanımı - Google Patents

HDAC inhibitörlerinin lenfoma tedavisine yönelik olarak kullanımı

Info

Publication number
TR200809829T1
TR200809829T1 TR2008/09829T TR200809829T TR200809829T1 TR 200809829 T1 TR200809829 T1 TR 200809829T1 TR 2008/09829 T TR2008/09829 T TR 2008/09829T TR 200809829 T TR200809829 T TR 200809829T TR 200809829 T1 TR200809829 T1 TR 200809829T1
Authority
TR
Turkey
Prior art keywords
treatment
lymphoma
hdac inhibitors
radicals
medicament
Prior art date
Application number
TR2008/09829T
Other languages
English (en)
Inventor
Wisdom Atadja Peter
Shao Wenlin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR200809829T1 publication Critical patent/TR200809829T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş, özelliklen tanımlanmış radikaller ve semboller içeren bir HDAC inhibitörünün, lenfoproliferatif hastalıkların, özellikle,cilt T-hucre lenfomasının tedavisi için bir ilacın hazırlanmasına yönelik kullanımı ile ilgilidir.
TR2008/09829T 2006-06-28 2007-06-26 HDAC inhibitörlerinin lenfoma tedavisine yönelik olarak kullanımı TR200809829T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80602606P 2006-06-28 2006-06-28

Publications (1)

Publication Number Publication Date
TR200809829T1 true TR200809829T1 (tr) 2009-06-22

Family

ID=38617341

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2008/09829T TR200809829T1 (tr) 2006-06-28 2007-06-26 HDAC inhibitörlerinin lenfoma tedavisine yönelik olarak kullanımı

Country Status (6)

Country Link
US (2) US20090281159A1 (tr)
CA (1) CA2654936A1 (tr)
EE (1) EE200800070A (tr)
MX (1) MX2008016503A (tr)
TR (1) TR200809829T1 (tr)
WO (1) WO2008002634A1 (tr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002015921A2 (en) * 2000-08-18 2002-02-28 The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor
US7402603B2 (en) * 2001-11-06 2008-07-22 Novartis Ag Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination

Also Published As

Publication number Publication date
MX2008016503A (es) 2009-06-08
CA2654936A1 (en) 2008-01-03
EE200800070A (et) 2009-02-16
WO2008002634A1 (en) 2008-01-03
US20110124701A1 (en) 2011-05-26
US20090281159A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
CY1114518T1 (el) Πεπτιδο εποξυκετονες για αναστολη πρωτεασωματος
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
TR201708567T4 (tr) Sigma ligandların kemik kanseri ağrısında kullanımı.
NO20082120L (no) Behandling og forebyggelse av mikroangiopati
UA100250C2 (uk) Інгібітори реплікації вірусу імунодефіциту людини
CL2008003405A1 (es) Compuestos derivados de tienopiridina, inhibidores de la enzima integrasa del vih; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion por vih.
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
ECSP099376A (es) Inhibidores de la actividad de la akt
MY148495A (en) Oral compositions for treating tooth sensitivity and methods of use and manufacture thereof
HK1125040A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
MA35638B1 (fr) 2-thiopyrimidinones
MX2009010485A (es) Derivados de imidazolidinacarboxamida como inhibidores de lipasas y fosfolipasas.
BRPI0916540B8 (pt) inibidores do canal de ânion de superficíe de plasmódio como agentes antimaláricos
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
EA200970529A1 (ru) Антивирусная композиция и способ ее применения
MX2010001300A (es) Uso de hesperidina o un derivado de la misma para prevencion y/o tratamiento de pieles flacidas.
EA200900691A1 (ru) Применение ингибиторов iap для лечения острого миелоидного лейкоза
EA201170821A1 (ru) Энзастаурин для лечения рака
EA200970284A1 (ru) Ингибиторы гистоновых дезацетилаз с сочетанной активностью в отношении гистоновых дезацетилаз класса i и класса ii в комбинации с ингибиторами протеасом
CY1115194T1 (el) Χρηση της μακρας πεντραξινης ptx3 για την προληψη ή θεραπεια ιικων ασθενειων
MX2011007373A (es) Metodos para identificar pacientes que responderan bien a tratamiento para el cancer.
MX2013003903A (es) Nuevos tratamientos de infeccion por el virus de hepatitis c.
TR200809829T1 (tr) HDAC inhibitörlerinin lenfoma tedavisine yönelik olarak kullanımı
ATE552888T1 (de) Elastasehemmer bei leukämie